Abstract

International direct-to-participant (DTP) genomics research involves the use of mobile technology to recruit, consent, and study participants remotely. This model can facilitate research across broad geographies and many countries, but must also comply with the norms of multiple recruitment jurisdictions, with each jurisdiction typically requiring at least one local research ethics review. Each additional research ethics review increases bureaucratic hurdles without necessarily strengthening the protection of participants’ rights and interests. For DTP genomic research, obtaining a review may in fact be impossible in the absence of a local research partner. This paper proposes an “adequacy” approach, inspired by data protection law, to coordinate the regulation and oversight of international DTP genomics research. This involves one country voluntarily assessing whether another country’s research ethics reviews are equivalent to its own, in terms of objectives and effectiveness. Ethics-approved projects led by researchers from countries recognized as adequate are deemed to comply with local norms, eliminating the need for a duplicative local review. Adequacy preserves the sovereignty of countries to determine their own regulatory aims and which other countries to trust. It therefore provides a voluntary, incremental path towards greater global coordination of health research oversight.

Highlights

  • Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations

  • Philosophies 2021, 6, 93 country, as well as in each country where participants are recruited [1,3]. This survey explored requirements applying to international DTP genomic research, including institutional review board (IRB)

  • A central finding of the study was that most countries require a local IRB review of foreign-led DTP genomic research projects

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Philosophies 2021, 6, 93 country, as well as in each country where participants are recruited [1,3] This survey explored requirements applying to international DTP genomic research, including IRB review, informed consent, local collaborators, restrictions on cross-border sample and data transfers, and rules specific to human genetic research. A central finding of the study was that most countries require a local IRB review of foreign-led DTP genomic research projects This duplicative oversight is potentially unnecessary, increasing paperwork and delays without necessarily strengthening protections for human subjects or research validity. Without a local collaborator or recruiting site, it may be impossible for a foreign-led DTP project to obtain a local IRB approval To address this problem, Rothstein et al have proposed that the duplicative ethics review of international DTP genomics research can be eliminated by an “adequacy” approach [1]. We conclude that adequacy presents a cautious and viable way forward to improve the global coordination of health research regulation and oversight

Adapting Data Protection Adequacy to Research Ethics Review
Data Protection Adequacy
Step One
Step 2
Step 3 Issuing an Adequacy Decision
Advantages
Disadvantages
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.